ARTICLES BY THIS AUTHOR
- 11/4/2013
New option for pancreatic cancer
- 11/4/2013
Communication problems plague transfers and handovers
Patient safety is being put at risk, according to staff and residents - 11/4/2013
Intuniv XR: first alpha agonist approved for ADHD
Shire Canada is introducing Intuniv XR (guanfacine 1 mg, 2 mg, 3mg, and 4 mg extended-release tablets), the first selective alpha2A-adrenergic receptor agonist to be approved for the treatment of attention deficit hyperactivity disorder (ADHD) in Canada. - 11/4/2013
Every bit of activity helps
- 11/4/2013
It is an honour to care for you
The faint blue lines on my patient’s forearm started a conversation that has given me strength and hope - 11/4/2013
Chemicals in plastics linked with fertility problems
Miscarriages and pregnancy delays among outcomes studied - 11/4/2013
Scene: Honouring Gairdner recipients